Procenttallene for gastrisk ulcusfri patienter var 51%, 93%, 80% og 82% for hhv. placebo, misoprostol, lansoprazol 15 mg og lansoprazol 30 mg- gruppen.
By week 12, the percentages of gastric ulcer-free patients were 51%, 93%, 80% and 82% for the placebo, misoprostol, lansoprazole 15 mg and lansoprazole 30 mg group, respectively.